To explore direct functional effects of APRIL on CLL cells, we transduced NIH-3T3 cells (DSMZ, Braunschweig, Germany) with three different membrane-docked APRIL constructs (Figure 2a). This evidence concerns the gene TNFSF13 and B-cell chronic lymphocytic leukemia.